期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Therapeutic options and vaccine development in the treatment of leishmaniasis
1
作者 jill e weatherhead Laila Woc-Colburn 《World Journal of Pharmacology》 2015年第2期210-218,共9页
Early treatment of leishmaniasis is critical to achieve cure, prevent psychological and social distress, and prevent transmission of disease. Untreated Leishmaniasis-cutaneous leishmaniasis, mucocutaneous leishmaniasi... Early treatment of leishmaniasis is critical to achieve cure, prevent psychological and social distress, and prevent transmission of disease. Untreated Leishmaniasis-cutaneous leishmaniasis, mucocutaneous leishmaniasis and visceral leishmaniasis - results in disfguring scars and high rates of morbidity and mortality in highly endemic regions of the world. However, cure rates with available therapeutics are limited due to cost, therapeutic toxicity and the growing rate of resistance. New therapeutic targets for medications and vaccine development are under investigation to provide improved healing and effcacy for the treatment of Leishmania spp. 展开更多
关键词 LEISHMANIA VISCERAL CUTANEOUS Mucocutaneous Amphoterecin VACCINE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部